Strickler, J. H., Nemunaitis, J. J., Weekes, C. D., Ramanathan, R. K., Angevin, E., Morgensztern, D., … Kelly, K. (2016). Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors. In Journal of Clinical Oncology (Vol. 34, pp. 2510–2510). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.2510

Strickler, John H., John J. Nemunaitis, Colin D. Weekes, Ramesh K. Ramanathan, Eric Angevin, Daniel Morgensztern, Rebecca Suk Heist, et al. “Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors.” In Journal of Clinical Oncology, 34:2510–2510. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.2510.

Strickler JH, Nemunaitis JJ, Weekes CD, Ramanathan RK, Angevin E, Morgensztern D, et al. Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 2510–2510.

Strickler, John H., et al. “Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. 2510–2510. Crossref, doi:10.1200/jco.2016.34.15_suppl.2510.

Strickler JH, Nemunaitis JJ, Weekes CD, Ramanathan RK, Angevin E, Morgensztern D, Heist RS, Bauer TM, Kaminker P, Fan X, Siggelkow S, Wong S, Reilly EB, Afar DE, Naumovski L, Kelly K. Phase 1, open-label, dose-escalation and expansion study of ABBV-399, an antibody drug conjugate (ADC) targeting c-Met, in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 2510–2510.